Tool

Semaglutide Calculator

A reconstitution, concentration and volume calculator for semaglutide. Enter the milligrams in the vial, the diluent volume added and the milligram figure you want to convert — it returns the mg/mL concentration, the corresponding volume in mL and the equivalent U-100 syringe units, with the arithmetic shown for every result. Because semaglutide figures are frequently sub-milligram, this page pays particular attention to milligram–microgram conversion. It performs mathematics only and does not recommend, prescribe or personalise any dose or titration schedule.

Back to the main Semaglutide information page

Inputs

Total peptide in the lyophilised vial.

Bacteriostatic water or other diluent added.

Amount you want to draw in a single measurement.

U-100 syringes: 100 units = 1 mL.

Used to calculate what is left in the vial.

Results

Concentration

2.5 mg/mL

5 mg ÷ 2 mL = 2.5 mg/mL

Required volume

0.1 mL

0.25 mg ÷ 2.5 mg/mL = 0.1 mL

Syringe units (U-100)

10 units

0.1 mL × 100 units/mL = 10 units

Equal portions in vial

20 (20 whole)

5 mg ÷ 0.25 mg = 20

Remaining after 1 portion

4.75 mg · 1.9 mL

5 mg − (1 × 0.25 mg) = 4.75 mg

These are arithmetic conversions of the numbers you entered. They are not a dose recommendation.

What the Semaglutide Calculator does

Semaglutide is quantified in milligrams, and in clinical use the quantities involved are small — the approved products are labelled in fractions of a milligram. A syringe, by contrast, measures volume in millilitres or in the unit markings printed on an insulin barrel. This calculator converts between the two. Give it the milligrams contained in a vial and the millilitres of diluent added to it, and it derives the concentration in mg/mL, then translates any milligram figure you enter into the matching volume and U-100 syringe-unit equivalent.

It also reports how many equal portions of a given size a vial mathematically contains, and how much material and liquid remain after a chosen number of those portions have been withdrawn. Each output appears next to the arithmetic that produced it, so every number can be reproduced on paper.

This is a units-conversion tool, not a clinical one. It holds no dosing table, no titration ladder and no recommendation for any individual. Semaglutide is a prescription medicine; how much a person should use, and whether they should use it at all, is a decision for a licensed prescriber working from an approved product label.

How to use the calculator

  1. Vial amount (mg). Enter the total milligrams the vial contains, taken from the label. Research-supplied semaglutide vials are commonly labelled 2, 3, 5 or 10 mg. Enter the vial total here, not the amount you plan to measure.
  2. Reconstitution volume (mL). Enter the diluent volume you actually added — normally bacteriostatic water. This one number sets the concentration for everything that follows.
  3. Amount to measure (mg). Enter the milligram figure you want expressed as a volume. Semaglutide figures are often below 1 mg, so enter values like 0.25 or 0.5 rather than microgram numbers such as 250.
  4. Syringe size (mL). Choose 0.3 mL (30 units), 0.5 mL (50 units) or 1 mL (100 units). Small semaglutide volumes usually land on a 0.3 mL barrel, where the markings are furthest apart and easiest to read. If a volume will not fit in a single draw, the calculator says so rather than returning an impossible figure.
  5. Portions already drawn. Optional. Enter how many equal portions have already been removed to see what remains, in both mg and mL.

Results update as you type. Copy results places the whole calculation, inputs included, on your clipboard; Reset restores the starting values.

What semaglutide concentration means

Concentration states how much peptide sits in each millilitre of liquid, written mg/mL. A lyophilised vial has no concentration until it is reconstituted — 5 mg of powder is simply 5 mg. Add 2 mL of bacteriostatic water and that 5 mg is spread through 2 mL, giving 2.5 mg/mL. Add 5 mL to the same vial and it becomes 1 mg/mL.

Semaglutide makes this unusually consequential because the quantities are small. At 2.5 mg/mL, 0.25 mg occupies 0.1 mL — ten units on a U-100 barrel. Reconstitute the identical vial in 1 mL instead and the concentration becomes 5 mg/mL, so the same 0.25 mg occupies only 0.05 mL, or five units. A single mis-read gradation at that scale is a large proportional error, which is why more dilute solutions produce longer, easier-to-read volumes.

Approved semaglutide products are supplied as ready-made solutions at fixed concentrations and are not reconstituted by the user at all; this calculator exists for people working with lyophilised material, and the arithmetic it performs is generic to any mg-in-a-vial preparation.

How mg/mL is calculated

Concentration is one division:

Concentration (mg/mL) = Vial amount (mg) ÷ Diluent volume (mL)

Turning a milligram figure into a volume is the same relationship rearranged:

Volume (mL) = Amount (mg) ÷ Concentration (mg/mL)

The two collapse into volume = (amount mg × diluent mL) ÷ vial mg, but the calculator keeps the concentration visible as its own line because that intermediate value is where mistakes become obvious. If you expect roughly 2.5 mg/mL and see 25 mg/mL, a decimal point has moved.

Converting volume into syringe units

Insulin syringes are graduated in units, not millilitres. The U-100 standard defines 100 units as 1 mL, which gives a fixed conversion that has nothing to do with the peptide involved:

Syringe units = Volume (mL) × 100

So 0.1 mL is 10 units, 0.06 mL is 6 units and 0.34 mL is 34 units. A 0.3 mL barrel is marked to 30 units, a 0.5 mL barrel to 50 and a 1 mL barrel to 100; the spacing between units is identical on all three, only the capacity differs. A unit is always a volume marking and never a quantity of peptide — 10 units of a 2.5 mg/mL solution contains 0.25 mg, while 10 units of a 5 mg/mL solution contains 0.5 mg.

Worked mathematical examples

These are arithmetic illustrations of the formulas above using hypothetical numbers. They demonstrate unit conversion and carry no clinical meaning whatsoever — they are not dosing suggestions.

Example 1 — 5 mg vial, 2 mL diluent

  • Concentration = 5 mg ÷ 2 mL = 2.5 mg/mL
  • Volume for 0.25 mg = 0.25 ÷ 2.5 = 0.1 mL
  • Syringe units = 0.1 × 100 = 10 units
  • Portions of 0.25 mg = 5 ÷ 0.25 = 20
  • Remaining after 4 portions = 5 − 1 = 4 mg (1.6 mL)

Example 2 — same vial, 1 mL diluent

  • Concentration = 5 ÷ 1 = 5 mg/mL
  • Volume for 0.25 mg = 0.25 ÷ 5 = 0.05 mL = 5 units

Identical milligrams, half the volume, and a reading only five gradations up the barrel. Nothing changed except the dilution.

Example 3 — 10 mg vial, 2 mL diluent

  • Concentration = 10 ÷ 2 = 5 mg/mL
  • Volume for 1 mg = 1 ÷ 5 = 0.2 mL = 20 units
  • Volume for 1.7 mg = 1.7 ÷ 5 = 0.34 mL = 34 units — exceeds a 0.3 mL syringe
  • Portions of 1 mg = 10 ÷ 1 = 10

Example 4 — a figure that does not divide evenly

  • Concentration = 3 mg ÷ 1.5 mL = 2 mg/mL
  • Volume for 0.4 mg = 0.4 ÷ 2 = 0.2 mL = 20 units
  • Portions of 0.35 mg = 3 ÷ 0.35 = 8.571 → 8 whole portions, 0.2 mg left over

The calculator reports the exact fractional count and the number of whole portions separately instead of hiding the remainder in a rounded figure.

mg vs mL vs syringe units

  • Milligram (mg) — a mass. It says how much semaglutide is present and does not change when water is added.
  • Microgram (mcg) — one thousandth of a milligram. 250 mcg is 0.25 mg. This calculator works in milligrams, so convert first.
  • Millilitre (mL) — a volume. It says how much liquid is in the syringe and nothing about the peptide inside it.
  • Syringe unit — a marking on a U-100 barrel equal to 1/100 mL. A volume label, not a mass.

Concentration is the only bridge between mass and volume. "X units equals Y mg" is meaningless unless the mg/mL concentration is stated with it.

Common calculation mistakes

  • Entering micrograms as milligrams. The dominant error with semaglutide specifically, because the familiar figures are sub-milligram. Typing 250 instead of 0.25 inflates the result by a factor of one thousand.
  • Treating units as milligrams. Units measure volume; the milligrams they represent depend entirely on the concentration.
  • Using the intended diluent volume rather than the added one. If you meant to add 2 mL but added 1.8 mL, every downstream number is wrong. Enter what went in.
  • Assuming dilution changes the total. More water never creates more peptide; a 5 mg vial holds 5 mg at any concentration.
  • Reading a non-U-100 syringe as U-100. U-40 barrels and 3 mL luer-lock syringes use different graduations entirely.
  • Rounding too early. Rounding the concentration before dividing compounds the error. The calculator carries full precision internally and rounds only for display.

Limitations and safety considerations

The arithmetic assumes the diluent volume you enter is the final solution volume and that the powder dissolves completely and evenly. In practice the solid contributes a small volume of its own, and residual liquid remains on the vial walls and in the needle hub, so the final portion in a vial is often slightly short of the theoretical value. Vial fill quantities carry manufacturing tolerance, and material sold as a research chemical is not subject to the identity, purity and content verification applied to a licensed medicine — a milligram figure on such a label is an assumption, not a measurement.

Beyond the maths, semaglutide is a prescription-only medicine with a documented adverse-effect profile and specific contraindications recorded in its approved labelling, and regulators including the FDA and MHRA have issued public warnings about counterfeit and unapproved semaglutide products obtained outside the regulated supply chain. Those are clinical and legal matters that a calculator cannot address. See our medical disclaimer for the full scope of what this site does and does not do.

Semaglutide's clinical and regulatory status

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk. Unlike investigational compounds, it is an approved medicine: the FDA and the EMA have authorised semaglutide products for type 2 diabetes and, at higher strengths, for chronic weight management, each with its own approved label, indications and prescribing information. Structural modification — including fatty-acid acylation that promotes albumin binding — gives it a half-life of roughly one week, which is what makes once-weekly administration possible.

The evidence base is large and peer-reviewed. The SUSTAIN programme examined glycaemic outcomes in type 2 diabetes, the STEP programme examined weight outcomes in obesity, and SELECT (published in the New England Journal of Medicine in 2023) reported cardiovascular outcomes in people with overweight or obesity and established cardiovascular disease without diabetes. Gastrointestinal adverse events are the most commonly reported in these trials. This background is factual context only; nothing here indicates that semaglutide is appropriate for any particular person.

For mechanism of action, half-life, administration route, reported effects and our evidence grading, see the full Semaglutide profile.

Related pages

Sources & references

  • U.S. Food and Drug Administration — Drugs@FDA approved product records and prescribing information for semaglutide products.
  • European Medicines Agency — European public assessment reports (EPAR) for semaglutide-containing medicines.
  • Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389:2221–2232.
  • Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989–1002.
  • ClinicalTrials.gov — SUSTAIN, STEP and SELECT trial records for semaglutide.
  • Novo Nordisk — official product and pipeline information for semaglutide.

Educational and mathematical content only. Nothing here is medical advice or a dosing recommendation.